Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) earnings · P/E 40, rev $3.02B
These earnings events as JSON? API free 100/dayAmneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This AMRX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AMRX revenue for 2025-12-31 was $3.02B. Net income was $72.1M. Revenue was up 8.0% from 2024-12-31 to 2025-12-31. AMRX currently screens at market cap $5.19B and trailing P/E 40.0.
When the next AMRX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 8.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AMRX research stays on the stock page; the tape stays on the quote page.
AMRX earnings FAQ
What are AMRX's latest revenue and net income?
Latest cached Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) revenue for Dec 31, 2025 was $3.02B. Net income was $72.1M. Statements: https://lician.com/financials/amrx
What is AMRX's latest diluted EPS?
Latest cached Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) diluted EPS for Dec 31, 2025 was $0.22.
What period does the latest AMRX earnings print cover?
The latest cached Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did AMRX revenue change from the prior cached period?
Cached Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) revenue was up 8.0% from $2.79B (Dec 31, 2024) to $3.02B (Dec 31, 2025). Statements: https://lician.com/financials/amrx
What is AMRX's P/E ratio?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) trailing P/E is 40.0 on the latest cached fundamentals snapshot.
Where are AMRX earnings listed?
Cached earnings facts for Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) are listed at https://lician.com/earnings/amrx. Statements: https://lician.com/financials/amrx
Not investment advice.